Registration & Pricing Information
Main Conference
Industry$1495.00
- Full access to all conference sessions and exhibits
- Includes: breakfast, morning and afternoon refreshments, lunches and cocktail reception
- Access to conference mobile and web-based app for networking and other features
- NOTE: Sponsorships, which include multiple conference passes, are available. Please contact us for more information.
- Does NOT include workshops
Government/Non-Profit/Academic/Clinician$695.00
- Full access to all conference sessions and exhibits
- Includes: breakfast, morning and afternoon refreshments, lunches and cocktail reception
- Access to conference mobile and web-based app for networking and other features
- NOTE: Sponsorships, which include multiple conference passes, are available. Please contact us for more information.
- Does NOT include workshops
Graduate Students/Fellows$495.00
- Full access to all conference sessions and exhibits
- Includes: breakfast, morning and afternoon refreshments, lunches and cocktail reception
- Access to conference mobile and web-based app for networking and other features
- NOTE: Sponsorships, which include multiple conference passes, are available. Please contact us for more information.
- Does NOT include workshops
Undergraduate Students*$395.00
- Full access to all conference sessions and exhibits
- Includes: breakfast, morning and afternoon refreshments, lunches and cocktail reception
- Access to conference mobile and web-based app for networking and other features
- NOTE: Sponsorships, which include multiple conference passes, are available. Please contact us for more information.
- Does NOT include workshops
- * Student rate only applies to full-time students with no industry affiliations. Arrowhead reserves the right to request proof of student status
Workshops
Workshop I$345.00
Psychedelic Patents—Avoiding Controversy While Achieving Defensible and Enforceable IP
(MORE DETAILS COMING SOON)
Most will agree that patents are necessary for drug development, because without the reward of exclusivity, the investment in trials can be impossible to justify, and new drugs may never reach the market. But how can strong IP be built around known psychedelic compounds, or even variations of them, especially in a crowded field with many close competitors, with significant uncertainties around REMS—and in view of controversies around whether patents should be granted on psychedelics at all? How can a patent strategy be best designed to account for these difficulties, while taking advantage of regulatory exclusivities and other incentive mechanisms to bring innovative therapeutics into the clinic and to patients?
(MORE DETAILS COMING SOON)
Most will agree that patents are necessary for drug development, because without the reward of exclusivity, the investment in trials can be impossible to justify, and new drugs may never reach the market. But how can strong IP be built around known psychedelic compounds, or even variations of them, especially in a crowded field with many close competitors, with significant uncertainties around REMS—and in view of controversies around whether patents should be granted on psychedelics at all? How can a patent strategy be best designed to account for these difficulties, while taking advantage of regulatory exclusivities and other incentive mechanisms to bring innovative therapeutics into the clinic and to patients?
Workshop II$345.00
Psychedelics & Clinical Trials: Site Feasibility and Audit Preparedness
FDA-approved clinical trials are critically important for psychedelics to becoming accepted and recognized as substances with approved medical use. Psychedelics such as MDMA and psilocybin are approaching federal regulatory approval for use to treat depression, anxiety, and a variety of substance use disorders. Many innovators and scientists are interested in running clinical trials in order to prove safety and efficacy and as a necessary step to eventual commercialization. The speakers will provide an overview of current psychedelic clinical trials for certain mental health and behavioral health treatments, outline some of the requirements for clinical site feasibility, licensing requirements that sponsors will need to bear in mind when choosing a clinical trial site, the challenges of running and operating clinical trials for Schedule I drugs, and areas of concern in order to be prepared for a clinical site audit.
FDA-approved clinical trials are critically important for psychedelics to becoming accepted and recognized as substances with approved medical use. Psychedelics such as MDMA and psilocybin are approaching federal regulatory approval for use to treat depression, anxiety, and a variety of substance use disorders. Many innovators and scientists are interested in running clinical trials in order to prove safety and efficacy and as a necessary step to eventual commercialization. The speakers will provide an overview of current psychedelic clinical trials for certain mental health and behavioral health treatments, outline some of the requirements for clinical site feasibility, licensing requirements that sponsors will need to bear in mind when choosing a clinical trial site, the challenges of running and operating clinical trials for Schedule I drugs, and areas of concern in order to be prepared for a clinical site audit.
Substitution/Cancellation Policy
Your registration may be transferred to a member of your organization up to 24 hours in advance of the conference. Refunds (minus a $30 processing fee) are available if cancellation is received at least 14 days before the event. No cancellations can be accepted within 14 days of the event, but voucher will be issued for attendance at a future Arrowhead event.
Your registration may be transferred to a member of your organization up to 24 hours in advance of the conference. Refunds (minus a $30 processing fee) are available if cancellation is received at least 14 days before the event. No cancellations can be accepted within 14 days of the event, but voucher will be issued for attendance at a future Arrowhead event.
Arrowhead reserves the right to request proof of status and institutional affiliation as pertains to various registration rates outlined above
